Search - tctmd.com

Displaying 101 - 120 of 821

Sort: Relevancy | Date

News Daily News

Polypills Added to List of WHO’s Essential Medicines

Michael O'Riordan

August 02, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Daily News

SGLT2i May Be Helpful Early After Acute MI in Diabetic Patients

Todd Neale

July 17, 2023

News Daily News

More Data Show Redlining’s Lasting Impact on CVD Risk

L.A. McKeown

July 14, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Daily News

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Michael O'Riordan

June 30, 2023

News Daily News

Wintertime Brings Increased IHCA Risk, US Data Show

Caitlin E. Cox

June 26, 2023

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

News Opinion CV Team Dispatch

June 2023 News Roundup

L.A. McKeown

June 01, 2023

News Conference News SCAI 2023

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

L.A. McKeown

May 30, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

Todd Neale

May 05, 2023

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

News Daily News

Rehospitalizations After Acute MI: Young Women Outpace Young Men

L.A. McKeown

May 03, 2023

News Daily News

Sugary Drinks Up CVD and All-Cause Mortality Risks in Type 2 Diabetes

Michael O'Riordan

May 01, 2023

News Opinion CV Team Dispatch

May 2023 News Roundup

L.A. McKeown

May 01, 2023

News Conference News ACC 2023

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Michael O'Riordan

March 13, 2023

News Conference News ACC 2023

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

L.A. McKeown

March 10, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

Advertisement

Polypills Added to List of WHO’s Essential Medicines

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

SGLT2i May Be Helpful Early After Acute MI in Diabetic Patients

More Data Show Redlining’s Lasting Impact on CVD Risk

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Wintertime Brings Increased IHCA Risk, US Data Show

CABG and PCI Comparable in ACS Patients With Left Main CAD

June 2023 News Roundup

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Rehospitalizations After Acute MI: Young Women Outpace Young Men

Sugary Drinks Up CVD and All-Cause Mortality Risks in Type 2 Diabetes

May 2023 News Roundup

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content